Impact Factor
4.31
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
7.18
1,921 total citations
h5-index
48
h5 depth signal
Cited share
87.8%
251 of 286
Total citations
1,921
Citation footprint
Metric signal
7.53
External metric anchor
Self-citation
0.7%
13 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
643
United States
260
Japan
62
United Kingdom
46
Iran
46
Citing Fields of Research
Cancer & Development
360
Noncoding RNA
289
Oncology
261
Immunology
204
Cancer, Autophagy & Apoptosis
193
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,968
Articles tracked across the journal lifetime
Indexed publication set
286
251 cited publications
Last 12 months
118
9.8 publications/month
Open access share
34.7%
41 OA publications in the last year
Leading citing country
China
643 citing publications
Leading citing field
Cancer & Development
360 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v1n1,Mar. 1994-
v1n1,Mar. 1994-
Active Coverage
Research Focus & Classification
Indexed Subjects
Cancer & Development
Cancer, Autophagy & Apoptosis
Noncoding RNA
Immunology
Oncology
Lung Cancer
Broad Categories
Genetics, Medical
Neoplasms
Therapeutics
Noncoding RNA
Cancer & Development
Cancer, Autophagy & Apoptosis
Immunology
Viral Identification & Phylogenetics
DNA Damage
MeSH Descriptors
Genetic Therapy
Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1038/s41417-026-01092-x
Open DOI
CircRNA-mediated regulation of ferroptosis in cancer: mechanistic networks and therapeutic implications
Ferroptosis is an iron-dependent form of regulated cell death driven by lipid peroxidation. In cancer, metabolic reprogramming is characterized by enhanced iron uptake, altered lipid metabolism, and sustained oxidative stress, creating a...
02
DOI 10.1038/s41417-026-01085-w
Open DOI
Restoration of p53 function via hybrid strontium sulfite nanoparticles modified LNP improves the antitumor efficacy in breast cancers
The astounding success of mRNA empowers the diverse application of mRNA therapeutics in multiple genetic disorders. Besides the vaccines, the rational design of mRNA drugs has been explored widely to target the undruggable gene therapy f...
03
DOI 10.1038/s41417-026-01088-7
Open DOI
LAMB3 orchestrates EGFR-MAPK-PKM cascade to promote glycolytic reprogramming and progression in laryngeal carcinoma
Laryngeal carcinoma (LC) remains a challenging malignancy with poor prognosis, necessitating the identification of novel therapeutic targets. This study investigates the functional role and underlying mechanism of the extracellular matri...
04
DOI 10.1038/s41417-026-01079-8
Open DOI
Whole-genome DNA methylation analysis reveals distinct subtype characteristics in epithelial ovarian cancer
05
DOI 10.1038/s41417-026-01089-6
Open DOI
RSL24D1 links ribosome biogenesis to p53 activation in melanoma
Melanoma cells exhibit elevated translation activity and rely on intact ribosomes to sustain their high protein synthesis demand. To support this process, efficient ribosome biogenesis is essential. RSL24D1 is a ribosome biogenesis facto...
06
DOI 10.1038/s41417-026-01086-9
Open DOI
METTL3-mediated m⁶A methylation of E2F2 targets MCU to promote the malignant phenotype of gastric cancer cells
Gastric cancer (GC) is a highly prevalent malignancy worldwide, and its progression is closely linked to aberrant epigenetic regulation. E2F transcription factor 2 (E2F2), a member of the E2F transcription factor family, has been identif...
07
DOI 10.1038/s41417-026-01084-x
Open DOI
E2F3 amplification primes bladder cancer cells for premature mitosis
The E2F–RB pathway controls the G1/S checkpoint, and tumors often bypass it through RB1 or CDKN2A loss. Unlike these lesions, E2F3 amplification drives persistent excessive E2F-dependent transcription through S and G2 phases. This oncoge...
08
DOI 10.1038/s41417-026-01083-y
Open DOI
POLE2 of tumor cells promotes OPN secretion based on PCLAF to drive M2 macrophage polarization in clear cell renal cell carcinoma
The malignant progression of renal cell carcinoma (RCC) is closely associated with the establishment of an immunosuppressive tumor microenvironment (TME). This study aims to elucidate the oncogenic functions of DNA polymerase ε subunit P...
09
DOI 10.1038/s41417-026-01082-z
Open DOI
Targeted degradation of protein in hematologic malignancies: mechanisms, therapeutic strategies, and clinical prospects
Hematological malignancies, including leukemia, lymphoma, and multiple myeloma, remain a major cause of illness and death worldwide. Although treatment options such as targeted therapies and immunotherapies have improved survival and cli...
10
DOI 10.1038/s41417-026-01081-0
Open DOI
TWF1 inhibition overcomes cisplatin resistance in NSCLC by inducing ferroptosis via p53-dependent SLC7A11 repression and autophagy-mediated glutathione metabolism reprogramming
Non-small-cell lung cancer (NSCLC) ranks among the most prevalent causes of cancer-related mortality worldwide, with cisplatin-based chemotherapy being a cornerstone of clinical treatment despite the inevitable emergence of drug resistan...
Bibliographical & Catalog Notes
Title from cover.
Place of publication varies.
Also issued online.